Trademark Overview
On Tuesday, April 23, 2024, a trademark application was filed for PULSESIGHT THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the PULSESIGHT THERAPEUTICS trademark a serial number of 79401614. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, August 8, 2024. This trademark is owned by PULSESIGHT THERAPEUTICS. The PULSESIGHT THERAPEUTICS trademark is filed in the Pharmaceutical Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceuticals; chemical-pharmaceutical products; veterinary preparations; chemical products, biochemical products, biotechnological products for medical, pharmaceutical and veterinary purposes; pharmaceutical and veterinary preparations for the treatment of disorders in the field of ophthalmology and eye health; diagnostic preparations for medical, pharmaceutical or veterinary purposes; preparations for medical, pharmaceutical or veterinary purposes for the diagnosis and treatment of ocular disorders.
Medical services; health care; medical services in the field of ophthalmology and eye health.
Surgical and medical apparatus and instruments; ophtalmic surgical and medical apparatus and instruments.
Medical research; medical and scientific research in the field of retinal medicine and treatments; medical and scientific research in the field of eye health; medical research in the field of ophthalmology; scientific research for medical purposes in the area of ophthalmology; scientific research for medical purposes in the area of retinal and ophthalmologic diseases and conditions; scientific research for medical purposes in the area of retinal and ophthalmologic treatments and pharmaceuticals; pharmaceutical research and development; pharmaceutical research and development for retinal and ophthalmologic diseases and conditions; pharmaceutical research and development for improving eye health.
